AndroGel Lawsuit Update: Dates Set for 2016 & 2017 Trials

“Low-T,” a condition created largely using aggressive pharmaceutical marketing efforts, is treated using supplemental testosterone therapy products. Of products used to treat “Low T,” AndroGel is the most commonly prescribed. However, due to questionable marketing tactics and an increased risk of potentially deadly side effects, several lawsuits have been filed against AndroGel’s manufacturer, AbbVie, Inc. The most recent AndroGel lawsuit updates have

Read the full article…

AndroGel Lawsuit Update: The Caseload Is Growing

According to the latest AndroGel lawsuit updates, the legal teams involved are currently in the process of selecting cases for the upcoming bellwether trials anticipated in the fall of next year. These trials will test more than 2,000 claims that the health risks associated with AndroGel, a gel used in testosterone replacement therapy, were not fully disclosed to patients. Once cases

Read the full article…